Clinical trial Recruiting at 1 site Observational Ages 4 to 17

French version of the OSA-18 questionnaire validation

Official title: Validation of the French Version of the OSA-18 Questionnaire

Run by Hospices Civils de Lyon · NCT07136909 · Data updated 2026-11-12

This study tests whether a French version of the OSA-18 questionnaire is valid for measuring pediatric obstructive sleep apnea symptoms and their impact as reported by caregivers.

Quick facts

Study typeObservational
Ages4 Years to 17 Years
SexAll
Enrollment200 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Bron, Rhône)
StatusRecruiting
StartedJune 29, 2026
Main results expectedJanuary 29, 2028
Study endsJanuary 29, 2028
Registry record updatedJuly 1, 2026
Trial IDNCT07136909 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 4 to 17 years hospitalized for polysomnography screening for suspected pediatric OSA whose caregivers consent to participate.

Probably not a fit

Patients whose caregivers decline participation or whose clinical assessment determines the questionnaire is not applicable may not benefit from this validation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the validity of a French translation of the 18-item OSA-18 questionnaire, completed by parents during a routine hospitalization for overnight sleep studies in children aged 4 to 17. The goal is to determine whether the French version reliably captures OSA symptoms and their effects on the child’s daily life. Data are collected in a real-world clinical setting at a single center, with comparison to standard clinical assessments. The study does not test an intervention, but the questionnaire may be useful for monitoring treatment outcomes in future interventional work and routine practice.

Why it matters

Potential benefit: If validated, the French OSA-18 could provide a reliable caregiver-reported tool to track symptom burden and the impact of treatment in French-speaking pediatric patients.

How similar studies have gone: Other language validations of the OSA-18 have shown utility in capturing caregiver-reported OSA impact, supporting the potential value of this French validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children hospitalized in the Clinical Epileptology, Sleep Disorders, and Child Functional Neurology Department for polysomnography to screen for OSA,
* Aged 4 to 17 years inclusive.

Exclusion Criteria:

* Parents and/or children object to participation in the study.
* Subjects participating in another intervention research study with an ongoing exclusion period.

Where it's running

  • Hôpital Femme-Mère-Enfant
    Bron, Rhône, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.